2e9c759af1d11415ca1bf2a5abc7a087.jpg

European Patent Granted for OPM’s OsteoFab 3D Printed Implants 3D Printing Processes

by Medical

Oxford Performance Materials, Inc. (OPM), a leader in advanced materials science and high performance additive manufacturing (HPAM), today announced that it has received a Notice of Decision to Grant a Patent from the European Patent Office (EPO) for OPM’s invention on a “Customized Implant for Bone Replacement”, which leverages its OsteoFab implant manufacturing process, originally filed on December 5, 2011. The patent, which took effect on December 21, 2016, will be valid until August 7, 2029, and enables OPM to apply its high-performance additive manufacturing process to 3D print customized implants for bone replacement.

36afe6214e38e6adc63d9876c1b2d52e.jpg

CeramicSpeed Introduces 3D Printed Titanium Oversized Pulley and Outboard Headset to Bespoke Bike Consumer Products

by Consumer

In a format where handmade bicycles, creativity and design join forces, CeramicSpeed launches the 3D printed hollow Titanium Oversized Pulley Wheels and their first outboard headset offering. A custom-made display bike has been designed in an original joint collaboration together with Mosaic Cycles and ENVE for the North American Handmade Bicycle Show, where the new products will be introduced.

ad3418b026f6c3a5dbf4028ee509d6dd.jpg

Stratasys FY2016 losses reduced significantly, slow business improvement AM Industry

by Business

Stratasys, the current 3D printing industry market leader in terms of global sales, reported revenues $672.5 million in Stratasys FY2016 results compared to $696.0 million for fiscal 2015. This relatively contained decrement came with a huge reduction in GAAP net losses: $77.2 million, or ($1.48) per diluted share, compared to $1.4 billion, or ($26.64) per diluted share, for fiscal 2015.

a9bd79ef9a69352aa7c54735e1afe2af.jpg

Stratasys Opens Enrollment for 3DHEART Clinical Study on Effects of 3D Printed Heart Models in Surgery 3D Printing Processes

by Medical

Stratasys, the 3D printing and additive manufacturing solutions market leader, today announced enrollment is now open for 3DHEART, an investigator initiated trial. 3DHEART, which stands for 3D Hearts Enabling A Randomized Trial, is a randomized, single-blind clinical trial to study the use of patient-specific 3D printed models in pre-operative planning for pediatric heart surgery. Stratasys is providing in-kind support with printing of the models to be used in the trial.